| Jana Rosanne Prichard, BS, OTR/L | |
|
2427 Russellville Rd, Bowling Green, KY 42101-3980 | |
| (270) 936-7472 | |
| (317) 520-8200 |
| Full Name | Jana Rosanne Prichard |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2427 Russellville Rd, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679127500 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | (* (Not Available)) | Secondary |
| 225X00000X | Occupational Therapist | 132705 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jana Rosanne Prichard, BS, OTR/L 3500 Depauw Blvd Ste 3070, Indianapolis, IN 46268-6135 Ph: (855) 324-0885 | Jana Rosanne Prichard, BS, OTR/L 2427 Russellville Rd, Bowling Green, KY 42101-3980 Ph: (270) 936-7472 |
News Archive
Vivolux AB, a drug discovery company specialized in cancer treatment, announced today that the FDA has granted clearance to proceed with VLX600 into the clinical phase I/II. VLX600 is one of the company's promising projects, and which was recently published in the journal Nature Communications.
Arthrobotrys oligospora doesn't live a charmed life; it survives on a diet of roundworm. But a discovery by a team led by Mingjun Zhang, an associate professor of biomedical engineering at the University of Tennessee, Knoxville, could give the fungus's life more purpose-as a cancer fighter.
VTT Technical Research Centre of Finland, GE Healthcare, a division of the General Electric Company (NYSE: GE) and a Consortium of leading research institutions across Europe announced the PredictAD project, a research collaboration aimed at developing new diagnostic procedures for patients with Alzheimer's disease.
A new clinical imaging method developed in collaboration with a University of Exeter academic may enable doctors to tackle one of the main killers of patients with weakened immune systems sooner and more effectively.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced the first patients have been treated in its Phase 2 clinical trial of EMA401 in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
› Verified 4 days ago
Kimberly Thompson, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 High St, Bowling Green, KY 42101 Phone: 270-843-3296 | |
Bri'enne Marie Greenwell, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 High St, Bowling Green, KY 42101 Phone: 270-843-3296 | |
Lauren Nicole Arbuckle, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1053 Lovers Ln, Bowling Green, KY 42103 Phone: 502-633-1007 | |
Mrs. Sarah Houchin Moody, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 840 Albemarle Dr, Bowling Green, KY 42103 Phone: 270-202-8808 | |
Brandi Wolf, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 165 Natchez Trace Ave Ste 200, Bowling Green, KY 42103 Phone: 270-796-4698 | |
Jessica Graves, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1329 Scottsville Rd, H6, Bowling Green, KY 42104 Phone: 502-345-3365 | |
Ms. Elizabeth Cooper Porter, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 210 Traditions Ave, Bowling Green, KY 42103 Phone: 606-303-8634 Fax: 317-520-8200 |